Home › Drug maker Transcept rejects Shkreli play to boost ownership stake
 

Keywords :   


Drug maker Transcept rejects Shkreli play to boost ownership stake

2013-10-01 04:47:27| Biotech - Topix.net

Transcept Pharmaceuticals Inc. rejected a request from Retrophin Inc. to triple its ownership stake in the Richmond drug developer from 4.9 percent to up to 15 percent.

Tags: play drug ownership maker

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
17.11LivreIPEF30/+
17.11Episode41
17.11CDCD
17.11TR3.5 30g 2
17.11
17.11 Fender mij traditional 60s stratcaster
17.11G
17.11WOMEN
More »